BRF’s Response amid of COVID-19

Below is the BRF’s research summary (last 4 months): COVID-19 related works

Published (or in process of publication) 

  1. Morshed et al 2020. Clinical manifestations of patients with Coronavirus Disease 2019 (COVID- 19) attending at hospitals in Bangladesh: MedRvix doi: (also under review in Journal of medical virology  
  2. Jahidur (Khan) et al 2020. Healthcare Capacity, Health Expenditure, and Civil Society as Predictors of COVID-19 Case Fatalities: A Global Analysis Jahidur Rahman Khan Frontiers in  Public Health 8:347. doi: 10.3389/fpubh.2020.00347 
  3. Sorowar et al 2020. Mass panic during Covid-19 outbreak- A perspective from Bangladesh as a high-risk country. Journal of Biomedical Analytics, 3(2), 1-3.  
  4. Siam et al 2020. Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment and Control Measures (Conditionally accept in The pathogen, Hindawi publisher (waiting for final acceptance) 

Under review: 

  1. Siam and Mahbub (co-first author) et al 2020. Insights into the first wave of the COVID-19 pandemic in Bangladesh: Lessons learned from a high-risk country ( Original article Frontiers in Public Health
  2. Meshbah et al 2020. Prevalence and correlation of symptoms and comorbidities in COVID-19 patients: A systematic review and meta-analysis (BMJ Global Health 
  3. Siam and Mosabbir (co-first author) et al 2020. Clinical spectrum, geographical variability of COVID-19 and its implications (Coronavirus, Bentham publisher)
  4. Sorowar et al 2020. The forgotten people with thalassemia in the time of COVID-19: South Asian perspective. Orphanet Journal of Rare Diseases (BMC) 

Under preparation 

  1. Karim et al 2020. Immunomodulatory therapies for SARS-CoV-2 infection and COVID-19 (targeted to submit in Nature Immunology or Nature Reviews Microbiology). One of the topmost immunologists (Prof Melief, Reza PhD supervisor)  in the world will contribute to this manuscript  
  2. Morshed et al 2020. Clinical symptoms and  outcome of COVID-19 hospitalized patients in Bangladesh (300+ cases  are being analyzed)
  3. Sorowar et al 2020. Why do suspected COVID-19 patients and people at risk not interested in seeking healthcare service in Bangladesh? (original article, 2600+ enrolled in an online survey).
  4. Sorowar et al 2020. Increased rates of COVID-19 related deaths among migrant Bangladeshis – What could be potential factors? (some data collected)- Perspective/viewpoint article
  5. Sorowar et al 2020. Impact of COVID-19 Pandemic on thalassemia patients in Bangladesh- A situation analysis at the community level (data collection is done), Perspective/viewpoint article
  6. COVID-19 and SUNRISE study (24 hours activities of children under 6 years)- Lead by Professor Tony Okely, University of Wollongong. BRF has contributed in this project.

BRF in Mainstream: 

BRF researchers are active to make awareness about the safety of COVID-19 vaccine candidate trial issues in Bangladesh   

Why safety comes first for vaccine development in Bangladesh ( TBS News and Dhaka Tribute, Dr. Reza and Dr Sorowar) 

ভ্যাকসিন ও বায়োটেক ড্রাগ তৈরিতে বাংলাদেশ কি সক্ষমতা অর্জন করেছে? যুগান্তর, Dr Sorowar and Dr Reza) 


Channel 24: Dr Sorowar’s interview on vaccine safety (করোনার ভ্যাক্সিনের ঝুঁকি এবং তাড়াহুড়া প্রসংগ- বাংলাদেশে চায়নিজ ভ্যাক্সিন কেন্ডিডেটের ট্রায়াল (ফেইজ-৩)। (এটি ২৫ মিনিটের ভিডিও ক্লিপ, ড সরোয়ার এর অংশ 2.5 এবং 10.5 min) 

Channel 24: Dr Reza in vaccine issue  

Part I: Vaccine immunology 

Part II: Ongoing development COVID-19 vaccines 

Part III: Vaccine trial on healthcare workers and other aspects  

Channel 24: Dr Reza on COVID-19 immunology  

Part I: আমাদের দেহের রোগ প্রতিরোধ ব্যবস্থা কিভাবে ভাইরাসের আক্রমণ থেকে সুরক্ষা দেয়? 

Part II: করোনা ভাইরাসে আক্রান্ত হয়ে নারীদের তুলনায় ২ গুনেরও বেশি পুরুষ মারা যাচ্ছেন কি কারণে? 

Part III: রোগ প্রতিরোধ ক্ষমতার উপর ভিত্তি করে করোনা ভাইরাস বা COVID-19 চিকিৎসায় কি ওষুধ উদ্ভাবনের প্রচেষ্টা চলছে?